Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02420548 · ClinicalTrials.gov registry record · NA

Safe, Healthy, Adolescent Relationships and Peers

A NA study, sponsored by University of Oregon.

Completed
Registry status
NA
Development phase
122
Enrollment target

NCT02420548: Completed NA study, sponsored by University of Oregon.

NCT02420548 is a NA study that has completed, run by University of Oregon. The registered enrollment target is 122 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02420548, a NA study, has completed, sponsored by University of Oregon.

COMPLETED
Registry status
NA
Development phase
122 participants
Enrollment target

Study Summary

The Safe, Healthy, Adolescent Relationships and Peers study seeks to understand some of the factors that contribute to the behaviors and health of teen girls, such as girl's friendships, their dating behaviors, their risk-taking behaviors, and their knowledge about how to make healthy choices. This study will inform us on ways to help teen girls engage in safe and healthy relationships and adjustment.

Primary Outcome

Reduction in delinquent behaviors for teens participating in the intervention arm measured by official arrest records and standardized questionnaires, including the Youth Symptom inventory, the Elliott Self-report Delinquency Scale, the Achenbach System of Empirically Based Assessment, and the Parent Daily Report.

Interventions

  • BEHAVIORAL Services as Usual
  • BEHAVIORAL Parent Ed. and Youth Skills Coaching

Trial Details

FieldValue
Enrollment Target 122 participants
Start Date 2014-07-01
Est. Completion 2022-12-31
Phase NA
University of Oregon

63 total trials

What the finished NCT02420548 record still lists

NCT02420548 is an interventional study that assigns participants to a tested intervention. The registered 122 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 2 interventions - of which Services as Usual is the first listed.

NCT02420548 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02420548 about?

NCT02420548 is a clinical study titled "Safe, Healthy, Adolescent Relationships and Peers". The Safe, Healthy, Adolescent Relationships and Peers study seeks to understand some of the factors that contribute to the behaviors and health of teen girls, such as girl's friendships, their dating behaviors, their risk-taking behaviors, and their knowledge about how to make healthy choices. This ...

What is the current status of trial NCT02420548?

This trial is currently completed. It is a NA study. The enrollment target is 122 participants. The study started on 2014-07-01. Estimated completion is 2022-12-31.

What interventions are being tested in trial NCT02420548?

The interventions under investigation include: Services as Usual (BEHAVIORAL), Parent Ed. and Youth Skills Coaching (BEHAVIORAL).

Who is sponsoring clinical trial NCT02420548?

This trial is sponsored by University of Oregon, which has 63 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02420548's enrollment target sits among peer trials

122 762nd of 2000 higher than 1,239 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03363373 · 122 participants · Phase 2

    Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow

  • NCT03463954 · 122 participants · NA

    Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors

  • NCT04503265 · 122 participants · Phase 1

    A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

  • NCT04700527 · 122 participants · Phase 1

    The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02420548, the US trial registry maintained by the National Library of Medicine. NCT02420548 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.